Inventor · disambiguated record
Peter R. Guzzo
Also filed as: GUZZO PETER · GUZZO PETER R · GUZZO PETER ROBERT · VON UNGE SVERKER
43 granted patents·13 pending applications·198 citations·filing 2000–2023
97Inventor score
Top patents by PatentIndex Score
56 records- 0194US7541357B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninAMR TECHNOLOGY INC·Filed 2005·Granted Jun 2, 2009·24 cites·37 claims
- 0291US8697700B2Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereofSURMAN MATTHEW D·Filed 2011·Granted Apr 15, 2014·29 cites·23 claims
- 0389US8236796B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2009·Granted Aug 7, 2012·10 cites·46 claims
- 0489US8227486B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2008·Granted Jul 24, 2012·10 cites·19 claims
- 0588US7956050B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2006·Granted Jun 7, 2011·13 cites·28 claims
- 0686US8101632B25-furopyridinone substituted indazolesGUZZO PETER ROBERT·Filed 2008·Granted Jan 24, 2012·12 cites·24 claims
- 0785US6936611B2Serine protease inhibitorsLILLY CO ELI·Filed 2004·Granted Aug 30, 2005·20 cites·27 claims
- 0884US8273770B25-pyridinone substituted indazolesGUZZO PETER·Filed 2008·Granted Sep 25, 2012·10 cites·22 claims
- 0984US8268868B25-pyridinone substituted indazolesGUZZO PETER ROBERT·Filed 2008·Granted Sep 18, 2012·10 cites·36 claims
- 1081US9499531B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2015·Granted Nov 22, 2016·2 cites·6 claims
- 1181US6576626B2Aminopropylphosphinic acidsASTRAZENECA AB·Filed 2000·Granted Jun 10, 2003·15 cites·11 claims
- 1278US8193228B2Substituted imidazole as bombesin receptor subtype-3 modulatorsCHEN DAVID·Filed 2007·Granted Jun 5, 2012·4 cites·19 claims
- 1377US8716308B2(1-azinone)-substituted pyridoindolesGUZZO PETER·Filed 2009·Granted May 6, 2014·3 cites·66 claims
- 1477US6596711B1(Aminopropyl)methylphosphinic acidsASTRAZENECA AB·Filed 2000·Granted Jul 22, 2003·11 cites·11 claims
- 1576US7034176B2Aminopropylphosphinic acidsASTRAZENECA AB·Filed 2004·Granted Apr 25, 2006·9 cites·1 claims
- 1676US6841698B2Aminopropylphosphinic acidsASTRAZENECA AB·Filed 2003·Granted Jan 11, 2005·7 cites·9 claims
- 1774US6946467B2Serine protease inhibitorsLILLY CO ELI·Filed 2001·Granted Sep 20, 2005·5 cites·4 claims
- 1872US9650378B2(1-azinone)-substituted pyridoindolesALBANY MOLECULAR RES INC·Filed 2016·Granted May 16, 2017·1 cites·41 claims
- 1971US9296743B2(1-azinone)-substituted pyridoindolesALBANY MOLECULAR RES INC·Filed 2014·Granted Mar 29, 2016·1 cites·65 claims
- 2069US8791101B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2010·Granted Jul 29, 2014·1 cites·34 claims
- 2166US9562031B1Phenethyldihydrobenzodioxolones and methods of useSEQUOIA SCIENCES INC·Filed 2015·Granted Feb 7, 2017·1 cites·43 claims
- 2265US2023002377A1Therapeutic combinations of drugs and methods of using themHARMONY BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 2364US9352049B2Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using themALBANY MOLECULAR RES INC·Filed 2014·Granted May 31, 2016·0 cites·32 claims
- 2464US9085531B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2014·Granted Jul 21, 2015·0 cites·14 claims
- 2563US2009118260A1Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninAMR TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 2663US2025325571A1Treatment of binge eating disorder using psychedelicsTRYP THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2761US2024228460A1Protease inhibitors and methods of making sameVARIATIONAL AI INC·Filed 2023·Application pending·0 cites
- 2860US8741901B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2012·Granted Jun 3, 2014·0 cites·13 claims
- 2959US9403776B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2014·Granted Aug 2, 2016·0 cites·14 claims
- 3058US2023084144A1Therapeutic combinations of drugs and methods of using themCONSYNANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3158US2008146836A1New Aminopropylphosphinic acidsELEBRING THOMAS·Filed 2007·Application pending·0 cites
- 3255US8106070B2Substituted imidazoles as bombesin receptor subtype-3 modulatorsCHEN DAVID·Filed 2007·Granted Jan 31, 2012·0 cites·17 claims
- 3355US7351822B2Serine protease inhibitorsLILLY CO ELI·Filed 2004·Granted Apr 1, 2008·0 cites·3 claims
- 3455US2017204095A1(1-azinone)-substituted pyridoindolesALBANY MOLECULAR RES INC·Filed 2017·Application pending·0 cites
- 3553US9045501B25-HT3 receptor modulators, methods of making, and use thereofALBANY MOLECULAR RES INC·Filed 2014·Granted Jun 2, 2015·0 cites·14 claims
- 3653US2023105412A15-ht3 receptor modulator, the crystalline form, methods of making, and use thereofHUANG JINKUN·Filed 2021·Application pending·0 cites
- 3753US2016235858A1Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using themALBANY MOLECULAR RES INC·Filed 2016·Application pending·0 cites
- 3848US8039453B2Vinca derivativesALBANY MOLECULAR RES INC·Filed 2007·Granted Oct 18, 2011·0 cites·41 claims
- 3947US8318767B2Substituted imidazoles as bombesin receptor subtype-3 modulatorsCHEN DAVID·Filed 2011·Granted Nov 27, 2012·0 cites·9 claims
- 4047US2008125451A1Vinorelbine derivativesAMR TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 4146US9096546B2Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninGUZZO PETER R·Filed 2008·Granted Aug 4, 2015·0 cites·21 claims
- 4245US2014163012A1Pyrido-/azepino-benzofuran and pyrido-/azepino-benzothiophene mch-1 antagonists, methods of making, and use thereofALBANY MOLECULAR RES INC·Filed 2013·Application pending·0 cites
- 4344US10231953B2Inhibitors of bromodomainsZENITH EPIGENETICS LTD·Filed 2015·Granted Mar 19, 2019·0 cites·3 claims
- 4443US8710046B25-HT3 receptor modulators, methods of making, and use thereofGUZZO PETER R·Filed 2010·Granted Apr 29, 2014·0 cites·44 claims
- 4539US2005143427A1[B]-fused bicyclic proline derivatives and their use for treating arthritic conditionsFiled 2004·Application pending·0 cites
- 4638US8993765B2Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereofSURMAN MATTHEW D·Filed 2011·Granted Mar 31, 2015·0 cites·22 claims
- 4737US8183275B2Substituted imidazoles as bombesin receptor subtype-3 modulatorsDOBBELAAR PETER H·Filed 2007·Granted May 22, 2012·0 cites·15 claims
- 4836US9073925B2Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereofGUZZO PETER R·Filed 2010·Granted Jul 7, 2015·0 cites·28 claims
- 4936US9045468B22,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotoninGUZZO PETER R·Filed 2011·Granted Jun 2, 2015·0 cites·10 claims
- 5035US8629158B2Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereofGUZZO PETER R·Filed 2010·Granted Jan 14, 2014·0 cites·28 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →